CF PharmTech

CF PharmTech EBIT per Share

The EBIT per Share of CF PharmTech (2652.HK) as of Oct 11, 2026 is -0.02 CNY. In the previous year, EBIT per Share was 0.05 CNY — a change of -132.74% (lower).

EBIT per Share

-0.02CNY

YoY

-132.74%

Last updated:

EBIT per Share of CF PharmTech is 2025 -0.02 CNY. EBIT per Share of CF PharmTech was 2024 0.05 CNY. It decreases by -132.74% lower compared to the previous year.

The CF PharmTech EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2022
-0.17 CNY
Jan 1, 2023
0.06 CNY
Jan 1, 2024
0.05 CNY
Jan 1, 2025
-0.02 CNY
The CF PharmTech EBIT per Share history
YEAREBIT per ShareYoY
-0.02CNY-132.74%
0.05CNY-7.34%
0.06CNY-132.23%
-0.17CNY—
Access this data via the Eulerpool API
Get Free API Key

CF PharmTech Stock analysis

What does CF PharmTech do? CF PharmTech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CF PharmTech stock

EBIT per Share of CF PharmTech is -0.02 CNY in 2025.

EBIT per Share of CF PharmTech changed from 0.05 CNY to -0.02 CNY, representing a -132.74% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share CF PharmTech since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — CF PharmTech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — CF PharmTech